These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 401123)

  • 41. Epidermal growth factor and prolactin in human breast cyst fluid. Possible correlations with GCDFP-15.
    Collette J; Van Cauwenberge JR; Dejardin L; Carlisi A; Jaspar JM; Franchimont P
    Ann N Y Acad Sci; 1990; 586():146-57. PubMed ID: 2356996
    [No Abstract]   [Full Text] [Related]  

  • 42. [Products of exocrine secretion of the breast and breast cancer].
    Franchimont P; Collette J; Zangerle PF; Hendrick JC
    Ann Med Interne (Paris); 1984; 135(5):385-9. PubMed ID: 6486618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Morphofunctional findings in adenocarcinoma of endometrium.
    Eusebi V; Pelusi G; Bondi A; Morichelli MP; Ceccarelli C; Cavallina R; Mancini AM
    Tumori; 1984 Jun; 70(3):291-5. PubMed ID: 6204431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assay of GCDFP-15 by ELISA: an available method for in vitro studies of functional differentiation in human breast cancer.
    Revillion-Carette F; Hornez L; Vandewalle B; Lefebvre J
    Tumori; 1988 Dec; 74(6):669-74. PubMed ID: 3232212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody sources.
    Mazoujian G
    Am J Surg Pathol; 1991 Dec; 15(12):1207-8. PubMed ID: 1660678
    [No Abstract]   [Full Text] [Related]  

  • 46. Biological actions of prolactin in human breast cancer.
    Shiu RP; Murphy LC; Tsuyuki D; Myal Y; Lee-Wing M; Iwasiow B
    Recent Prog Horm Res; 1987; 43():277-303. PubMed ID: 3306837
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunohistochemical stains for breast cancer.
    Roche PC
    Mayo Clin Proc; 1994 Jan; 69(1):57-8. PubMed ID: 8271853
    [No Abstract]   [Full Text] [Related]  

  • 48. Binding properties of progesterone-binding Cyst protein, PBCP.
    Lea OA
    Steroids; 1988 Oct; 52(4):337-8. PubMed ID: 3250014
    [No Abstract]   [Full Text] [Related]  

  • 49. Double antibody radioimmunoassay for monitoring metastatic breast cancer.
    Schecter RL; Major PP; Kovac PE; Ishida M; Kovalik EC; Dion AS; Langleben A; Boileau G; Boos G; Panasci L
    Br J Cancer; 1988 Sep; 58(3):362-7. PubMed ID: 3179189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [BCA225].
    Kannagi R; Fujii M; Kumamoto K
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():709-13. PubMed ID: 20960855
    [No Abstract]   [Full Text] [Related]  

  • 51. Sequential galactosyltransferase and carcinoembryonic antigen levels in advanced breast carcinoma.
    Paone JF; Baker RR; Waalkes TP; Shaper JH
    J Surg Res; 1981 Oct; 31(4):269-73. PubMed ID: 6793792
    [No Abstract]   [Full Text] [Related]  

  • 52. [Surgical and hormonal treatment of breast carcinoma].
    SCHWAIGER M
    Dtsch Med Wochenschr; 1958 Apr; 83(14):540-4. PubMed ID: 13537688
    [No Abstract]   [Full Text] [Related]  

  • 53. Views on the treatment of carcinoma of the breast.
    VAN ZIJL FD
    S Afr Med J; 1958 Aug; 32(33):827-9. PubMed ID: 13580485
    [No Abstract]   [Full Text] [Related]  

  • 54. The diagnostic value of calciuria during hormonal treatment of metastasized mammary carcinoma.
    GERBRANDY J; HELLENDOORN HB
    Acta Endocrinol Suppl (Copenh); 1957; 24(Suppl 31):275-88. PubMed ID: 13443788
    [No Abstract]   [Full Text] [Related]  

  • 55. Hormonal treatment of metastatic carcinoma of the breast.
    BAKER WH; KELLEY RM; SOHIER WD
    Am J Surg; 1960 Apr; 99():538-43. PubMed ID: 13796040
    [No Abstract]   [Full Text] [Related]  

  • 56. Hormonal control of breast cancer.
    EDELSTYN GA
    Ir J Med Sci; 1958 Sep; 393():428-31. PubMed ID: 13574996
    [No Abstract]   [Full Text] [Related]  

  • 57. [GSA-2-binding glycoprotein (GBG) and GSA-2-binding glycoprotein 2 (GBG2)].
    Nakayama J; Katsuyama T; Maeda H; Okano A
    Nihon Rinsho; 1999 Dec; 57 Suppl():563-6. PubMed ID: 10778192
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hormone dependent carcinomas and possibilities of hormonal therapy].
    Sprung M
    Vojnosanit Pregl; 1969 May; 26(5):248-50. PubMed ID: 5194622
    [No Abstract]   [Full Text] [Related]  

  • 59. Hormonal modification in the treatment of disseminated cancer of the breast.
    TAYLOR SG
    Am J Med; 1956 Nov; 21(5):688-96. PubMed ID: 13362300
    [No Abstract]   [Full Text] [Related]  

  • 60. The influence of hormone therapy on metastatic mammary carcinoma.
    PETERS MV
    Surg Gynecol Obstet; 1956 May; 102(5):545-52. PubMed ID: 13311742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.